These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 1638280)
41. Antibodies to Trypanosoma cruzi among blood donors in Buenos Aires, Argentina. Blejer JL; Saguier MC; Salamone HJ Int J Infect Dis; 2001; 5(2):89-93. PubMed ID: 11468104 [TBL] [Abstract][Full Text] [Related]
42. Trends of T. cruzi infection based on data from blood bank screening. Zicker F; Martelli CM; de Andrade AL; Almeida e Silva S Rev Inst Med Trop Sao Paulo; 1990; 32(2):132-7. PubMed ID: 2128905 [TBL] [Abstract][Full Text] [Related]
43. Surveillance of Trypanosoma cruzi transmission by serological screening of schoolchildren. de Andrade AL; Zicker F; Luquetti AO; Oliveira RM; Silva SA; Souza JM; Martelli CM Bull World Health Organ; 1992; 70(5):625-9. PubMed ID: 1464149 [TBL] [Abstract][Full Text] [Related]
44. Seropositivity for anti-trypanosoma cruzi antibodies among blood donors of the "Hospital Universitário Regional do Norte do Paraná", Londrina, Brazil. Reiche EM; Inouye MM; Pontello R; Morimoto HK; Itow Jankevicius S; Matsuo T; Jankevicius JV Rev Inst Med Trop Sao Paulo; 1996; 38(3):233-40. PubMed ID: 9163992 [TBL] [Abstract][Full Text] [Related]
45. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Kirchhoff LV; Paredes P; Lomelí-Guerrero A; Paredes-Espinoza M; Ron-Guerrero CS; Delgado-Mejía M; Peña-Muñoz JG Transfusion; 2006 Feb; 46(2):298-304. PubMed ID: 16441610 [TBL] [Abstract][Full Text] [Related]
46. A comparative study of four serological methods for diagnosis of acute and chronic Chagas' disease in Brazilian patients. Schattschneider W; Lopes ER; De Alencar JE; Bienzle U; Feldmeier H Trop Geogr Med; 1992 Jul; 44(3):210-8. PubMed ID: 1455524 [TBL] [Abstract][Full Text] [Related]
47. A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. Almeida IC; Covas DT; Soussumi LM; Travassos LR Transfusion; 1997 Aug; 37(8):850-7. PubMed ID: 9280332 [TBL] [Abstract][Full Text] [Related]
48. Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center. Kessler DA; Shi PA; Avecilla ST; Shaz BH Transfusion; 2013 May; 53(5):1083-7. PubMed ID: 22897737 [TBL] [Abstract][Full Text] [Related]
49. Screening for Chagas' disease in HIV-positive immigrants from endemic areas. Rodríguez-Guardado A; Asensi Alvarez V; Rodríguez Perez M; Mejuto Alvarez P; Flores-Chavez M; Alonso González P; Cartón Sánchez JA Epidemiol Infect; 2011 Apr; 139(4):539-43. PubMed ID: 20546632 [TBL] [Abstract][Full Text] [Related]
50. PREVALENCE OF CHAGAS DISEASE AMONG BLOOD DONOR CANDIDATES IN TRIANGULO MINEIRO, MINAS GERAIS STATE, BRAZIL. Lopes Pda S; Ramos EL; Gómez-Hernández C; Ferreira GL; Rezende-Oliveira K Rev Inst Med Trop Sao Paulo; 2015 Dec; 57(6):461-5. PubMed ID: 27049698 [TBL] [Abstract][Full Text] [Related]
51. Survey on experiences with latex-Chagas-test in various countries. Enders B; Hungerer KD; Zwisler O Tropenmed Parasitol; 1975 Jun; 26(2):252-60. PubMed ID: 808885 [TBL] [Abstract][Full Text] [Related]
52. Chagas' disease: an algorithm for donor screening and positive donor counseling. Hamerschlak N; Pasternak J; Amato Neto V; de Carvalho MB; Guerra CS; Coscina AL; Ferreira OC; Rosenblit J; Szterling LN Rev Soc Bras Med Trop; 1997; 30(3):205-9. PubMed ID: 9197153 [TBL] [Abstract][Full Text] [Related]
53. Seroprevalence of Trypanosoma cruzi infection among blood donors in the state of Bahia, Brazil. Miranda DLP; Ribeiro G; Lanza FC; Santos FLN; Reis RB; Fraga DBM; Silva LK; Silva Neto MMD; Santana IJ; Reis MGD Rev Soc Bras Med Trop; 2019 Aug; 52():e20190146. PubMed ID: 31390443 [TBL] [Abstract][Full Text] [Related]
55. Seroprevalence and geographical distribution of sero-positive blood donors to Trypanosoma cruzi at the central blood bank of the National Medical Center "La Raza". González-Guzmán S; Paredes-Cervantes V; Bagu ET; Crescencio-Trujillo JA; Guerra-Marquez Á; Rivas N; Alejandre-Aguilar R; Bermúdez-Torres E; González-Cano P Transfusion; 2019 Feb; 59(2):639-647. PubMed ID: 30520031 [TBL] [Abstract][Full Text] [Related]
56. Trans-sialidase inhibition assay for the detection of Trypanosoma cruzi infection in blood donor samples from Argentina. Blejer JL; Sartor PA; Bottasso O; Salamone HJ; Leguizamón MS Vox Sang; 2008 Oct; 95(3):189-96. PubMed ID: 19121183 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas' disease. Oelemann WM; Teixeira MD; Veríssimo Da Costa GC; Borges-Pereira J; De Castro JA; Coura JR; Peralta JM J Clin Microbiol; 1998 Sep; 36(9):2423-7. PubMed ID: 9705367 [TBL] [Abstract][Full Text] [Related]
58. Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time. Sabino EC; Lee TH; Montalvo L; Nguyen ML; Leiby DA; Carrick DM; Otani MM; Vinelli E; Wright D; Stramer SL; Busch M; Transfusion; 2013 Jun; 53(6):1257-65. PubMed ID: 23002996 [TBL] [Abstract][Full Text] [Related]
59. The application of latent class analysis for diagnostic test validation of chronic Trypanosoma cruzi infection in blood donors. Langhi DM; Bordin JO; Castelo A; Walter SD; Moraes-Souza H; Stumpf RJ Braz J Infect Dis; 2002 Aug; 6(4):181-7. PubMed ID: 12204185 [TBL] [Abstract][Full Text] [Related]
60. [Serologic screening of infectious diseases in blood banks as an indicator of morbidity in the population]. de Andrade AL; Martelli CM; Pinheiro ED; Santana CL; Borges FP; Zicker F Rev Saude Publica; 1989 Feb; 23(1):20-5. PubMed ID: 2510247 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]